RUBIN JONATHAN (SVP, Chief Medical Officer) received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2024ACC: 0001104659-24-027581
Officer· SVP, Chief Medical Officer
Since Jan 2021
+29.70K
Net shares
Net buyer
$8.5K
Total sold
0
Open market trades
0B · 0S
5
Total transactions
30.75K acquired · 1.05K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+750.00
Price / share
—
Trade value
—
% of position
21.4%
2/22/2024
3.51K→4.26K
Common Stock
Direct
Shares
−303.00
Price / share
$27.94
Trade value
$8.47K
% of position
7.1%
2/22/2024
4.26K→3.96K
Total
Net shares
+447.00
Net value
-$8.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2024 | A · Award | +750.00 | — | — | 21.4% | 3.51K | 4.26K |
| Common Stock Direct | 2/22/2024 | F · Tax Withholding | −303.00 | $27.94 | $8.47K | 7.1% | 4.26K | 3.96K |
| Total | +447.00 | -$8.47K | ||||||
Derivative Transactions3
Restricted Stock Unit
Direct
Converts to
Common Stock
750.00 shares
Shares
−750.00
Strike price
Held after
1.50K
Exercisable
—
2/22/2024
Restricted Stock Unit
Direct
Converts to
Common Stock
5K shares
Shares
+5K
Strike price
Held after
5K
Exercisable
—
2/22/2024
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25K shares
Shares
+25K
Strike price
27.94
Held after
25K
Exercisable
—
2/22/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock750.00 shares | 2/22/2024 | D · Disposition | −750.00 | — | 1.50K | |
| Restricted Stock Unit Direct | Common Stock5K shares | 2/22/2024 | A · Award | +5K | — | 5K | |
| Employee Stock Option (Right to Buy) Direct | Common Stock25K shares | 2/22/2024 | A · Award | +25K | 27.94 | — | 25K |